Searchable abstracts of presentations at key conferences in endocrinology

ea0084ps3-14-124 | Thyroid Cancer CLINICAL 2 | ETA2022

Evaluating prognostic markers for stage migration in medullary thyroid cancer

Jager Eline , Metman Madelon , Burgerhof Hans , Kruijff Schelto , Links Thera

Background: Medullary thyroid cancer (MTC) is a rare malignancy with a variable and sometimes unpredictable disease course. To predict the course of disease more accurately at diagnosis, we introduce dynamic risk stratification by analyzing factors related to “stage migration” within the first 5 years after diagnosis.Methods: All patients diagnosed at the University Medical Center of Groningen between 1999 and 2015 were retrospectively studied....

ea0092op-01-01 | Oral Session 1: Highlights in Thyroidology: in Memory of Jacques Dumont | ETA2023

Patient-Derived medullary thyroid cancer organoids; a model for patient-tailored drug and tracer screening

Jager Eline , Sondorp Luc , Antunes Ines , Jansen Liesbeth , Brouwers Adrienne , Links Thera , Coppes Robert , Kruijff Schelto

Background: Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor derived from the parafollicular C-cells of the thyroid gland. Mutations in the gene encoding the Rearranged during Transfection (RET) tyrosine kinase, play a vital role in the development of MTCs. In patients with distant metastases, only targeted therapy can prolong survival. Tyrosine kinase inhibitors (TKIs) block tyrosine kinases such as RET and thereby inhibit tumor proliferation. However, it is diffic...